Unique Ingredient Identifier FZ989GH94E is listed as a unspecified ingredient
| RN | 9003-39-8 |
| NCIT | C77491 |
| RXCUI | 8610 |
| INN ID | 2549 |
UNII FZ989GH94E POVIDONE, UNSPECIFIED is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | TABLET | 0.97 mg |
| AURICULAR (OTIC) | SUSPENSION | NA |
| INTRAMUSCULAR | INJECTION | 0.9 % |
| INTRAVENOUS | INJECTABLE | 2 % |
| INTRAVENOUS | INJECTION | 1 % |
| IV(INFUSION) | INJECTION | NA |
| OPHTHALMIC | SOLUTION | 2 % |
| OPHTHALMIC | SOLUTION, DROPS | 1.8 % |
| OPHTHALMIC | SUSPENSION | 1.8 % |
| OPHTHALMIC | SUSPENSION, DROPS | 1.5 % |
| ORAL | CAPSULE | 130 MG |
| ORAL | CAPSULE, COATED PELLETS | 10.03 MG |
| ORAL | CAPSULE, COATED, SOFT GELATIN | 6.9 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, DELAYED RELEASE | 8.7 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 9.2 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 102.73 MG |
| ORAL | CAPSULE, HARD GELATIN | 50 MG |
| ORAL | CAPSULE, SOFT GELATIN | NA |
| ORAL | CAPSULE, SUSTAINED ACTION | 72 MG |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 10.43 MG |
| ORAL | DISPERSIBLE TABLET | 2 MG |
| ORAL | DROPS | NA |
| ORAL | GRANULE | 100 MG |
| ORAL | GRANULE, EFFERVESCENT | NA |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 75 MG |
| ORAL | GRANULE, FOR SUSPENSION | NA |
| ORAL | GRANULE, FOR SUSPENSION, EXTENDED RELEASE | NA |
| ORAL | POWDER, FOR ORAL SOLUTION | 4.5 MG |
| ORAL | POWDER, FOR ORAL SUSPENSION | 5.85 MG/5ML |
| ORAL | POWDER, FOR RECONSTITUTION | NA |
| ORAL | POWDER, FOR SUSPENSION | 35 MG/5ML |
| ORAL | SOLUTION | 250 MG/5ML |
| ORAL | SUSPENSION | 1.57 MG/1ML |
| ORAL | SUSPENSION, EXTENDED RELEASE | 5.21 MG/5ML |
| ORAL | TABLET (IMMED./COMP. RELEASE), COATED | 3 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 240 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL | 4 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 18 MG |
| ORAL | TABLET, CHEWABLE | 21 MG |
| ORAL | TABLET, COATED | 49.2 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 219.03 MG |
| ORAL | TABLET, DELAYED ACTION | 73.7 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 35 MG |
| ORAL | TABLET, DISPERSIBLE | 2 MG |
| ORAL | TABLET, EXTENDED RELEASE | 371.25 MG |
| ORAL | TABLET, FILM COATED | 116 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 15.03 MG |
| ORAL | TABLET, REPEAT ACTION | 10 MG |
| ORAL | TABLET, SUSTAINED ACTION | 300 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 17 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 53.33 MG |
| ORAL | TABLET, UNCOATED, TROCHE | 35 MG |
| SUBCUTANEOUS | IMPLANT | 6 MG |
| SUBLINGUAL | TABLET | 12 MG |
| TOPICAL | EMULSION, CREAM | NA |
| TOPICAL | LOTION | NA |
| TOPICAL | PATCH | NA |
| TOPICAL | SOLUTION | 4 %W/W |
| TRANSDERMAL | FILM, CONTROLLED RELEASE | 9.69 MG |
| TRANSDERMAL | PATCH, CONTROLLED RELEASE | 20 MG |
| TRANSDERMAL | SOLUTION | 2.44 % |
| VAGINAL | INSERT | 49 MG |
| VAGINAL | TABLET | 50 MG |